Status:
UNKNOWN
Surgical Versus Percutaneous Drainage in the Management of High Grade Pancreatic Trauma
Lead Sponsor:
Nanjing PLA General Hospital
Conditions:
Trauma
Pancreatic Trauma
Eligibility:
All Genders
18-75 years
Brief Summary
High-grade pancreatic injury is rare, and the reported complication and mortality are high. The optimal management strategy according to high-grade injuries remains controversial. The present study ...
Detailed Description
High-grade pancreatic trauma (HGPT), while uncommon, presents challenging diagnostic and therapeutic dilemmas to trauma surgeons. Multiple management strategies to HGPT have been reported, which was a...
Eligibility Criteria
Inclusion
- Patient diagnosed with high-grade pancreatic trauma by surgery
- Patient diagnosed with high-grade pancreatic trauma by computed tomography
- Patient diagnosed with high-grade pancreatic trauma by Endoscopic retrograde cholangiopancreatography (ERCP)
- Patient diagnosed with high-grade pancreatic trauma by Magnetic resonance cholangiopancreatography (MRCP)
Exclusion
- The patient underwent chemotherapies or radiotherapy
- Immune system disease
- Low-grade pancreatic trauma
- Accompanied by severe trauma to other organs
- End-stage chronic organ failure
- With multiple severe injuries
- Died within 24 h of admission
- Younger than 18 years
- Pregnant
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04335474
Start Date
January 1 2020
End Date
March 31 2023
Last Update
April 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hospital
Nanjing, China, 210000